{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from Bio import Entrez\n",
    "from Bio import Medline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "Entrez.email = '<email>'\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "term = \"HLA-DQB1\" # Definimos o termo de pesquisa"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Realizamos uma Query Geral para pesquisar pelo termo para ter uma ideia de quantos resultados de pesquisa existem\n",
    "handle = Entrez.egquery(term=term)\n",
    "egq_res = Entrez.read(handle)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Resultados em \"pubmed\": 3690\n"
     ]
    }
   ],
   "source": [
    "for _ in egq_res['eGQueryResult']:\n",
    "    if 'pubmed' in _.values():\n",
    "        print('Resultados em \"pubmed\":',_['Count'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "handle      = Entrez.esearch(db='pubmed',term=term, retmax=10)\n",
    "esearch_res = Entrez.read(handle)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['38056499', '38037899', '38022600', '38003999', '38002954', '37979046', '37958786', '37935218', '37934957', '37925849']"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lista_ids = esearch_res['IdList']\n",
    "lista_ids"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "handle   = Entrez.esummary(db='pubmed', id=','.join(lista_ids))\n",
    "esum_res = Entrez.read(handle)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'Item': [], 'Id': '38056499', 'PubDate': '2023 Dec 6', 'EPubDate': '2023 Dec 6', 'Source': 'HLA', 'AuthorList': ['Yang JJ', 'Oh HB'], 'LastAuthor': 'Oh HB', 'Title': 'Genomic full-length sequence of the novel HLA-DQB1*04:01:01:04 allele.', 'Volume': '', 'Issue': '', 'Pages': '', 'LangList': ['English'], 'NlmUniqueID': '101675570', 'ISSN': '2059-2302', 'ESSN': '2059-2310', 'PubTypeList': ['Journal Article'], 'RecordStatus': 'PubMed - as supplied by publisher', 'PubStatus': 'aheadofprint', 'ArticleIds': {'medline': [], 'pubmed': ['38056499'], 'doi': '10.1111/tan.15318'}, 'DOI': '10.1111/tan.15318', 'History': {'medline': ['2023/12/07 00:42'], 'pubmed': ['2023/12/07 00:42'], 'revised': '2023/11/21 00:00', 'received': '2023/11/19 00:00', 'accepted': '2023/11/24 00:00', 'entrez': '2023/12/06 19:13'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(0, attributes={}), 'FullJournalName': 'HLA', 'ELocationID': 'doi: 10.1111/tan.15318', 'SO': '2023 Dec 6;'}, {'Item': [], 'Id': '38037899', 'PubDate': '2023 Dec 1', 'EPubDate': '2023 Dec 1', 'Source': 'HLA', 'AuthorList': ['Marin Rubio LA', 'Ontañon J'], 'LastAuthor': 'Ontañon J', 'Title': 'Three novel variants of HLA-DQB1*06 identified by next-generation sequencing.', 'Volume': '', 'Issue': '', 'Pages': '', 'LangList': ['English'], 'NlmUniqueID': '101675570', 'ISSN': '2059-2302', 'ESSN': '2059-2310', 'PubTypeList': ['Journal Article'], 'RecordStatus': 'PubMed - as supplied by publisher', 'PubStatus': 'aheadofprint', 'ArticleIds': {'medline': [], 'pubmed': ['38037899'], 'doi': '10.1111/tan.15315'}, 'DOI': '10.1111/tan.15315', 'History': {'medline': ['2023/12/01 06:43'], 'pubmed': ['2023/12/01 06:43'], 'received': '2023/11/17 00:00', 'accepted': '2023/11/20 00:00', 'entrez': '2023/12/01 05:52'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(0, attributes={}), 'FullJournalName': 'HLA', 'ELocationID': 'doi: 10.1111/tan.15315', 'SO': '2023 Dec 1;'}, {'Item': [], 'Id': '38022600', 'PubDate': '2023', 'EPubDate': '2023 Nov 3', 'Source': 'Front Immunol', 'AuthorList': ['Stefańska K', 'Kurkowiak M', 'Piekarska K', 'Chruściel E', 'Zamkowska D', 'Jassem-Bobowicz J', 'Adamski P', 'Świątkowska-Stodulska R', 'Abacjew-Chmyłko A', 'Leszczyńska K', 'Zieliński M', 'Preis K', 'Zielińska H', 'Tymoniuk B', 'Trzonkowski P', 'Marek-Trzonkowska NM'], 'LastAuthor': 'Marek-Trzonkowska NM', 'Title': 'High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia.', 'Volume': '14', 'Issue': '', 'Pages': '1272021', 'LangList': ['English'], 'NlmUniqueID': '101560960', 'ISSN': '', 'ESSN': '1664-3224', 'PubTypeList': ['Journal Article'], 'RecordStatus': 'PubMed - indexed for MEDLINE', 'PubStatus': '', 'ArticleIds': {'medline': [], 'pubmed': ['38022600'], 'pmc': 'PMC10655094', 'pmcid': 'pmc-id: PMC10655094;', 'doi': '10.3389/fimmu.2023.1272021'}, 'DOI': '10.3389/fimmu.2023.1272021', 'History': {'medline': ['2023/12/01 06:44'], 'pubmed': ['2023/11/29 18:41'], 'received': '2023/08/03 00:00', 'accepted': '2023/10/09 00:00', 'entrez': '2023/11/29 15:27'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(41, attributes={}), 'FullJournalName': 'Frontiers in immunology', 'ELocationID': 'doi: 10.3389/fimmu.2023.1272021', 'SO': '2023;14:1272021'}, {'Item': [], 'Id': '38003999', 'PubDate': '2023 Nov 4', 'EPubDate': '2023 Nov 4', 'Source': 'Medicina (Kaunas)', 'AuthorList': ['Sernicola A', 'Mazzetto R', 'Tartaglia J', 'Ciolfi C', 'Miceli P', 'Alaibac M'], 'LastAuthor': 'Alaibac M', 'Title': 'Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders.', 'Volume': '59', 'Issue': '11', 'Pages': '', 'LangList': ['English'], 'NlmUniqueID': '9425208', 'ISSN': '1010-660X', 'ESSN': '1648-9144', 'PubTypeList': ['Journal Article', 'Review'], 'RecordStatus': 'PubMed - indexed for MEDLINE', 'PubStatus': 'epublish', 'ArticleIds': {'medline': [], 'pubmed': ['38003999'], 'pmc': 'PMC10673328', 'pmcid': 'pmc-id: PMC10673328;', 'doi': '10.3390/medicina59111950', 'pii': 'medicina59111950'}, 'DOI': '10.3390/medicina59111950', 'History': {'medline': ['2023/11/27 12:41'], 'pubmed': ['2023/11/25 12:45'], 'received': '2023/09/16 00:00', 'revised': '2023/10/27 00:00', 'accepted': '2023/11/02 00:00', 'entrez': '2023/11/25 01:19'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(97, attributes={}), 'FullJournalName': 'Medicina (Kaunas, Lithuania)', 'ELocationID': 'doi: 10.3390/medicina59111950', 'SO': '2023 Nov 4;59(11)'}, {'Item': [], 'Id': '38002954', 'PubDate': '2023 Oct 27', 'EPubDate': '2023 Oct 27', 'Source': 'Genes (Basel)', 'AuthorList': ['Rosewood TJ', 'Nho K', 'Risacher SL', 'Gao S', 'Shen L', 'Foroud T', 'Saykin AJ', \"On Behalf Of The Alzheimer's Disease Neuroimaging Initiative\"], 'LastAuthor': \"On Behalf Of The Alzheimer's Disease Neuroimaging Initiative\", 'Title': \"Genome-Wide Association Analysis across Endophenotypes in Alzheimer's Disease: Main Effects and Disease Stage-Specific Interactions.\", 'Volume': '14', 'Issue': '11', 'Pages': '', 'LangList': ['English'], 'NlmUniqueID': '101551097', 'ISSN': '', 'ESSN': '2073-4425', 'PubTypeList': ['Journal Article'], 'RecordStatus': 'PubMed - indexed for MEDLINE', 'PubStatus': 'epublish', 'ArticleIds': {'medline': [], 'pubmed': ['38002954'], 'pmc': 'PMC10671827', 'pmcid': 'pmc-id: PMC10671827;', 'doi': '10.3390/genes14112010', 'pii': 'genes14112010'}, 'DOI': '10.3390/genes14112010', 'History': {'medline': ['2023/11/27 12:43'], 'pubmed': ['2023/11/25 12:43'], 'received': '2023/09/11 00:00', 'revised': '2023/10/23 00:00', 'accepted': '2023/10/23 00:00', 'entrez': '2023/11/25 01:13'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(54, attributes={}), 'FullJournalName': 'Genes', 'ELocationID': 'doi: 10.3390/genes14112010', 'SO': '2023 Oct 27;14(11)'}, {'Item': [], 'Id': '37979046', 'PubDate': '2023 Nov 18', 'EPubDate': '2023 Nov 18', 'Source': 'Immunogenetics', 'AuthorList': ['Colakogullari M', 'Karatas L', 'Tatar Z'], 'LastAuthor': 'Tatar Z', 'Title': 'Investigating associations between HLA DQA1\\u2009~\\u2009DQB1 haplotypes, H. pylori infection, metaplasia, and anti-CagA IgA seropositivity in a Turkish gastritis cohort.', 'Volume': '', 'Issue': '', 'Pages': '', 'LangList': ['English'], 'NlmUniqueID': '0420404', 'ISSN': '0093-7711', 'ESSN': '1432-1211', 'PubTypeList': ['Journal Article'], 'RecordStatus': 'PubMed - as supplied by publisher', 'PubStatus': 'aheadofprint', 'ArticleIds': {'medline': [], 'pubmed': ['37979046'], 'doi': '10.1007/s00251-023-01325-5', 'pii': '10.1007/s00251-023-01325-5'}, 'DOI': '10.1007/s00251-023-01325-5', 'History': {'medline': ['2023/11/18 12:42'], 'pubmed': ['2023/11/18 12:42'], 'received': '2023/06/05 00:00', 'accepted': '2023/10/29 00:00', 'entrez': '2023/11/18 11:13'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(0, attributes={}), 'FullJournalName': 'Immunogenetics', 'ELocationID': 'doi: 10.1007/s00251-023-01325-5', 'SO': '2023 Nov 18;'}, {'Item': [], 'Id': '37958786', 'PubDate': '2023 Oct 31', 'EPubDate': '2023 Oct 31', 'Source': 'Int J Mol Sci', 'AuthorList': ['Gupta K', 'Wiener HW', 'Tiwari HK', 'Geisler WM'], 'LastAuthor': 'Geisler WM', 'Title': 'HLA-DQB1*06 and Select Neighboring HLA Variants Predict Chlamydia Reinfection Risk.', 'Volume': '24', 'Issue': '21', 'Pages': '', 'LangList': ['English'], 'NlmUniqueID': '101092791', 'ISSN': '', 'ESSN': '1422-0067', 'PubTypeList': ['Journal Article'], 'RecordStatus': 'PubMed - indexed for MEDLINE', 'PubStatus': 'epublish', 'ArticleIds': {'medline': [], 'pubmed': ['37958786'], 'pmc': 'PMC10647357', 'pmcid': 'pmc-id: PMC10647357;', 'doi': '10.3390/ijms242115803', 'pii': 'ijms242115803'}, 'DOI': '10.3390/ijms242115803', 'History': {'medline': ['2023/11/15 06:42'], 'pubmed': ['2023/11/14 06:42'], 'received': '2023/09/21 00:00', 'revised': '2023/10/25 00:00', 'accepted': '2023/10/27 00:00', 'entrez': '2023/11/14 02:09'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(24, attributes={}), 'FullJournalName': 'International journal of molecular sciences', 'ELocationID': 'doi: 10.3390/ijms242115803', 'SO': '2023 Oct 31;24(21)'}, {'Item': [], 'Id': '37935218', 'PubDate': '2023 Sep', 'EPubDate': '', 'Source': 'Acta Orthop Belg', 'AuthorList': ['Wang Y', 'Ming G', 'Gao B'], 'LastAuthor': 'Gao B', 'Title': 'A potential prognostic prediction model for metastatic osteosarcoma based on bioinformatics analysis.', 'Volume': '89', 'Issue': '3', 'Pages': '373-380', 'LangList': ['English'], 'NlmUniqueID': '2985165R', 'ISSN': '0001-6462', 'ESSN': '', 'PubTypeList': ['Journal Article'], 'RecordStatus': 'PubMed - indexed for MEDLINE', 'PubStatus': 'ppublish', 'ArticleIds': {'medline': [], 'pubmed': ['37935218'], 'doi': '10.52628/89.2.10491'}, 'DOI': '10.52628/89.2.10491', 'History': {'medline': ['2023/11/09 06:42'], 'pubmed': ['2023/11/08 00:42'], 'entrez': '2023/11/07 18:56'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(0, attributes={}), 'FullJournalName': 'Acta orthopaedica Belgica', 'ELocationID': 'doi: 10.52628/89.2.10491', 'SO': '2023 Sep;89(3):373-380'}, {'Item': [], 'Id': '37934957', 'PubDate': '2023 Nov 7', 'EPubDate': '2023 Nov 7', 'Source': 'Diabetes', 'AuthorList': ['Ilonen J', 'Kiviniemi M', 'El-Amir MI', 'Nygård L', 'Härkönen T', 'Lempainen J', 'Knip M', 'Finnish Pediatric Diabetes Register'], 'LastAuthor': 'Knip M', 'Title': 'Increased Frequency of the HLA-DRB1*04:04-DQA1*03-DQB1*03:02 Haplotype among HLA-DQB1*06:02 Positive Children with Type 1 Diabetes.', 'Volume': '', 'Issue': '', 'Pages': '', 'LangList': ['English'], 'NlmUniqueID': '0372763', 'ISSN': '0012-1797', 'ESSN': '1939-327X', 'PubTypeList': ['Journal Article'], 'RecordStatus': 'PubMed - as supplied by publisher', 'PubStatus': 'aheadofprint', 'ArticleIds': {'medline': [], 'pubmed': ['37934957'], 'doi': '10.2337/db23-0387', 'pii': '153750'}, 'DOI': '10.2337/db23-0387', 'History': {'medline': ['2023/11/07 18:42'], 'pubmed': ['2023/11/07 18:42'], 'received': '2023/10/05 00:00', 'accepted': '2023/10/20 00:00', 'entrez': '2023/11/07 16:22'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(0, attributes={}), 'FullJournalName': 'Diabetes', 'ELocationID': 'pii: db230387. doi: 10.2337/db23-0387', 'SO': '2023 Nov 7;'}, {'Item': [], 'Id': '37925849', 'PubDate': '2023 Dec', 'EPubDate': '2023 Oct 30', 'Source': 'Sleep Med', 'AuthorList': ['Wenz ES', 'Schinkelshoek MS', 'Kallweit U', 'Fronczek R', 'Rezaei R', 'Khatami R', 'Lammers GJ', 'Bassetti CLA'], 'LastAuthor': 'Bassetti CLA', 'Title': 'Narcolepsy type 1 and Sydenham chorea - Report of 3 cases and review of the literature.', 'Volume': '112', 'Issue': '', 'Pages': '234-238', 'LangList': ['English'], 'NlmUniqueID': '100898759', 'ISSN': '1389-9457', 'ESSN': '1878-5506', 'PubTypeList': ['Review', 'Journal Article'], 'RecordStatus': 'PubMed - indexed for MEDLINE', 'PubStatus': 'ppublish+epublish', 'ArticleIds': {'medline': [], 'pubmed': ['37925849'], 'doi': '10.1016/j.sleep.2023.10.028', 'pii': 'S1389-9457(23)00406-9'}, 'DOI': '10.1016/j.sleep.2023.10.028', 'History': {'medline': ['2023/11/30 06:44'], 'pubmed': ['2023/11/06 00:41'], 'received': '2023/06/26 00:00', 'revised': '2023/10/26 00:00', 'accepted': '2023/10/27 00:00', 'entrez': '2023/11/05 18:07'}, 'References': [], 'HasAbstract': IntegerElement(1, attributes={}), 'PmcRefCount': IntegerElement(0, attributes={}), 'FullJournalName': 'Sleep medicine', 'ELocationID': 'doi: 10.1016/j.sleep.2023.10.028', 'SO': '2023 Dec;112:234-238'}]"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "esum_res\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "handle = Entrez.efetch(db='pubmed',id=','.join(lista_ids),rettype='abstract',retmode='text')\n",
    "record = handle.read()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Resultados em \"pubmed\": 3690\n",
      "Top 10 artigos -> ['38056499', '38037899', '38022600', '38003999', '38002954', '37979046', '37958786', '37935218', '37934957', '37925849']\n"
     ]
    }
   ],
   "source": [
    "termo = 'hla-dqb1 '\n",
    "email = '<email>'\n",
    "teste = lit_search(email, termo)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. HLA. 2023 Dec 6. doi: 10.1111/tan.15318. Online ahead of print.\n",
      "\n",
      "Genomic full-length sequence of the novel HLA-DQB1*04:01:01:04 allele.\n",
      "\n",
      "Yang JJ(1), Oh HB(2).\n",
      "\n",
      "Author information:\n",
      "(1)Department of Laboratory Medicine, Korea University College of Medicine, \n",
      "Seoul, South Korea.\n",
      "(2)Department of Laboratory Medicine, Asan Medical Center, University of Ulsan \n",
      "College of Medicine, Seoul, South Korea.\n",
      "\n",
      "The sequence of HLA-DQB1*04:01:01:04 differs from HLA-DQB1*04:01:01:03 by four \n",
      "nucleotide deletion in intron 2.\n",
      "\n",
      "© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.\n",
      "\n",
      "DOI: 10.1111/tan.15318\n",
      "PMID: 38056499\n",
      "\n",
      "\n",
      "2. HLA. 2023 Dec 1. doi: 10.1111/tan.15315. Online ahead of print.\n",
      "\n",
      "Three novel variants of HLA-DQB1*06 identified by next-generation sequencing.\n",
      "\n",
      "Marin Rubio LA(1), Ontañon J(1).\n",
      "\n",
      "Author information:\n",
      "(1)Immunology Unit, Clinical Analysis Department, Albacete University Hospital \n",
      "Complex, Albacete, Spain.\n",
      "\n",
      "Characterization of HLA-DQB1*06:472, -DQB1*06:02:01:34 and -DQB1*06:04:01:06 \n",
      "alleles in Spanish individuals.\n",
      "\n",
      "© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.\n",
      "\n",
      "DOI: 10.1111/tan.15315\n",
      "PMID: 38037899\n",
      "\n",
      "\n",
      "3. Front Immunol. 2023 Nov 3;14:1272021. doi: 10.3389/fimmu.2023.1272021. \n",
      "eCollection 2023.\n",
      "\n",
      "High maternal-fetal HLA eplet compatibility is associated with severe \n",
      "manifestation of preeclampsia.\n",
      "\n",
      "Stefańska K(#)(1), Kurkowiak M(#)(2), Piekarska K(3)(4)(5), Chruściel E(2), \n",
      "Zamkowska D(1), Jassem-Bobowicz J(6), Adamski P(1), Świątkowska-Stodulska R(7), \n",
      "Abacjew-Chmyłko A(1), Leszczyńska K(1), Zieliński M(4), Preis K(1), Zielińska \n",
      "H(3)(4), Tymoniuk B(8), Trzonkowski P(4), Marek-Trzonkowska NM(2)(5).\n",
      "\n",
      "Author information:\n",
      "(1)Department of Gynecology and Obstetrics Medical University of Gdansk, Gdańsk, \n",
      "Poland.\n",
      "(2)International Centre for Cancer Vaccine Science (ICCVS), University of \n",
      "Gdańsk, Gdańsk, Poland.\n",
      "(3)Laboratory of Immunology and Clinical Transplantology, University Clinical \n",
      "Centre in Gdańsk, Gdańsk, Poland.\n",
      "(4)Department of Medical Immunology, Medical University of Gdansk, Gdańsk, \n",
      "Poland.\n",
      "(5)Laboratory of Immunoregulation and Cellular Therapies, Department of Family \n",
      "Medicine, Medical University of Gdansk, Gdańsk, Poland.\n",
      "(6)Department of Neonatology, Medical University of Gdansk, Gdańsk, Poland.\n",
      "(7)Department of Endocrinology and Internal Medicine, Medical University of \n",
      "Gdansk, Gdańsk, Poland.\n",
      "(8)Department of Immunology and Allergy, Medical University of Łódź, Łódź, \n",
      "Poland.\n",
      "(#)Contributed equally\n",
      "\n",
      "INTRODUCTION: Preeclampsia is responsible for more than 70 000 and 500 000 \n",
      "maternal and fetal deaths, respectively each year. Incomplete remodelling of the \n",
      "spiral arteries in placenta is the most accepted theory of preeclampsia \n",
      "pathogenesis. However, the process is complexed with immunological background, \n",
      "as pregnancy resembles allograft transplantation. Fetus expresses human \n",
      "leukocyte antigens (HLA) inherited from both parents, thus is semiallogeneic to \n",
      "the maternal immune system. Therefore, induction of fetal tolerance is crucial \n",
      "for physiological outcome of pregnancy. Noteworthy, the immunogenicity of \n",
      "discordant HLA antigens is determined by functional epitopes called eplets, \n",
      "which are continuous and discontinuous short sequences of amino acids. This way \n",
      "various HLA molecules may express the same eplet and some HLA incompatibilities \n",
      "can be more immunogenic due to different eplet combination. Therefore, we \n",
      "hypothesized that maternal- fetal HLA incompatibility may be involved in the \n",
      "pathogenesis of gestational hypertension and its progression to preeclampsia. We \n",
      "also aimed to test if particular maternal-fetal eplet mismatches are more prone \n",
      "for induction of anti- fetal HLA antibodies in gestational hypertension and \n",
      "preeclampsia.\n",
      "METHODS: High resolution next-generation sequencing of HLA-A, -B, -C, -DQB1 and \n",
      "-DRB1 antigens was performed in mothers and children from physiological \n",
      "pregnancies (12 pairs) and from pregnancies complicated with gestational \n",
      "hypertension (22 pairs) and preeclampsia (27 pairs). In the next step HLA eplet \n",
      "identification and analysis of HLA eplet incompatibilities was performed with in \n",
      "silico approach HLAMatchmaker algorithm. Simultaneously maternal sera were \n",
      "screened for anti-fetal HLA class I, class II and anti-MICA antibodies with \n",
      "Luminex, and data were analyzed with HLA-Fusion software.\n",
      "RESULTS: We observed that high HLA-C, -B, and DQB1 maternal-fetal eplet \n",
      "compatibility was associated with severe preeclampsia (PE) manifestation. Both \n",
      "quantity and quality of HLA epletmismatches affected the severity of PE. \n",
      "Mismatches in HLA-B eplets: 65QIA+76ESN, 70IAO, 180E, HLA-C eplets: 193PL3, \n",
      "267QE, and HLA-DRB1 eplet: 16Y were associated with a mild outcome of \n",
      "preeclampsia if the complication occurred.\n",
      "CONCLUSIONS: High HLA-C, HLA-DQB1 and HLA-B eplet compatibility between mother \n",
      "and child is associated with severe manifestation of preeclampsia. Both quantity \n",
      "and quality of maternal-fetal HLA eplet mismatches affects severity of \n",
      "preeclampsia.\n",
      "\n",
      "Copyright © 2023 Stefańska, Kurkowiak, Piekarska, Chruściel, Zamkowska, \n",
      "Jassem-Bobowicz, Adamski, Świątkowska-Stodulska, Abacjew-Chmyłko, Leszczyńska, \n",
      "Zieliński, Preis, Zielińska, Tymoniuk, Trzonkowski and Marek-Trzonkowska.\n",
      "\n",
      "DOI: 10.3389/fimmu.2023.1272021\n",
      "PMCID: PMC10655094\n",
      "PMID: 38022600 [Indexed for MEDLINE]\n",
      "\n",
      "Conflict of interest statement: The authors declare that the research was \n",
      "conducted in the absence of any commercial or financial relationships that could \n",
      "be construed as a potential conflict of interest. The author(s) declared that \n",
      "they were an editorial board member of Frontiers, at the time of submission. \n",
      "This had no impact on the peer review process and the final decision\n",
      "\n",
      "\n",
      "4. Medicina (Kaunas). 2023 Nov 4;59(11):1950. doi: 10.3390/medicina59111950.\n",
      "\n",
      "Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders.\n",
      "\n",
      "Sernicola A(1), Mazzetto R(1), Tartaglia J(1), Ciolfi C(1), Miceli P(1), Alaibac \n",
      "M(1).\n",
      "\n",
      "Author information:\n",
      "(1)Dermatology Unit, Department of Medicine (DIMED), University of Padua, 35121 \n",
      "Padova, Italy.\n",
      "\n",
      "HLA class II molecules are key factors determining susceptibility to autoimmune \n",
      "disorders, and their role in immune-mediated skin conditions such as psoriasis \n",
      "has been extensively investigated. However, there is currently little \n",
      "understanding of their role in antibody-mediated skin diseases such as \n",
      "autoimmune blistering disorders. We researched the available literature using \n",
      "PubMed to narratively review the current knowledge on HLA associations in \n",
      "antibody-mediated blistering skin pathologies. Our results summarized the risk \n",
      "alleles that are identified in the literature, together with certain known \n",
      "protective alleles: in the pemphigus group, alleles HLA-DQB1*0503 and \n",
      "HLA-DRB1*0402 are most commonly associated with disease; in the pemphigoid \n",
      "group, the most studied allele is HLA-DQB1*0301; in epidermolysis bullosa \n",
      "acquisita, few genetic studies are available; in dermatitis herpetiformis, the \n",
      "association with haplotypes HLA-DQ2 and HLA-DQ8 is strongly established; \n",
      "finally, in linear IgA bullous disease, specific HLA alleles may be responsible \n",
      "for pediatric presentations. Our current pathogenic understanding of this group \n",
      "of disorders assigns a key role to predisposing HLA class II alleles that are \n",
      "able to bind disease autoantigens and therefore stimulate antigen-specific \n",
      "autoreactive T cells. The latter engage B lymphocytes that will produce \n",
      "pathogenic autoantibodies. The distribution of HLA alleles and their disease \n",
      "associations are variable across demographics, and an in-depth pathogenetic \n",
      "understanding is needed to support associations between HLA alleles and disease \n",
      "phenotypes. Additionally, in a personalized medicine approach, the \n",
      "identification of HLA alleles associated with the risk of disease may become \n",
      "clinically relevant in identifying susceptible subjects that should avoid \n",
      "exposure to known triggers, such as medication, when possible.\n",
      "\n",
      "DOI: 10.3390/medicina59111950\n",
      "PMCID: PMC10673328\n",
      "PMID: 38003999 [Indexed for MEDLINE]\n",
      "\n",
      "Conflict of interest statement: The authors declare no conflict of interest.\n",
      "\n",
      "\n",
      "5. Genes (Basel). 2023 Oct 27;14(11):2010. doi: 10.3390/genes14112010.\n",
      "\n",
      "Genome-Wide Association Analysis across Endophenotypes in Alzheimer's Disease: \n",
      "Main Effects and Disease Stage-Specific Interactions.\n",
      "\n",
      "Rosewood TJ(1)(2)(3), Nho K(1)(3)(4), Risacher SL(1)(3), Gao S(1)(5), Shen L(6), \n",
      "Foroud T(1)(2), Saykin AJ(1)(2)(3), On Behalf Of The Alzheimer's Disease \n",
      "Neuroimaging Initiative.\n",
      "\n",
      "Author information:\n",
      "(1)Indiana Alzheimer's Disease Research Center, Indianapolis, IN 46202, USA.\n",
      "(2)Department of Medical and Molecular Genetics, Indiana University School of \n",
      "Medicine, Indianapolis, IN 46202, USA.\n",
      "(3)Department of Radiology and Imaging Sciences, Indiana University School of \n",
      "Medicine, Indianapolis, IN 46202, USA.\n",
      "(4)School of Informatics and Computing, Indiana University, Indianapolis, IN \n",
      "46202, USA.\n",
      "(5)Department of Biostatistics, Indiana University School of Medicine, \n",
      "Indianapolis, IN 46202, USA.\n",
      "(6)Department of Biostatistics, Epidemiology and Informatics, The Perelman \n",
      "School of Medicine, Philadelphia, PA 19104, USA.\n",
      "\n",
      "The underlying genetic susceptibility for Alzheimer's disease (AD) is not yet \n",
      "fully understood. The heterogeneous nature of the disease challenges genetic \n",
      "association studies. Endophenotype approaches can help to address this challenge \n",
      "by more direct interrogation of biological traits related to the disease. AD \n",
      "endophenotypes based on amyloid-β, tau, and neurodegeneration (A/T/N) biomarkers \n",
      "and cognitive performance were selected from the Alzheimer's Disease \n",
      "Neuroimaging Initiative (ADNI) cohort (N = 1565). A genome-wide association \n",
      "study (GWAS) of quantitative phenotypes was performed using an SNP main effect \n",
      "and an SNP by Diagnosis interaction (SNP × DX) model to identify disease \n",
      "stage-specific genetic effects. Nine loci were identified as study-wide \n",
      "significant with one or more A/T/N endophenotypes in the main effect model, as \n",
      "well as additional findings significantly associated with cognitive measures. \n",
      "These nine loci include SNPs in or near the genes APOE, SRSF10, HLA-DQB1, XKR3, \n",
      "and KIAA1671. The SNP × DX model identified three study-wide significant genetic \n",
      "loci (BACH2, EP300, and PACRG-AS1) with a neuroprotective effect in later AD \n",
      "stage endophenotypes. An endophenotype approach identified novel genetic \n",
      "associations and provided insight into the molecular mechanisms underlying the \n",
      "genetic associations that may otherwise be missed using conventional \n",
      "case-control study designs.\n",
      "\n",
      "DOI: 10.3390/genes14112010\n",
      "PMCID: PMC10671827\n",
      "PMID: 38002954 [Indexed for MEDLINE]\n",
      "\n",
      "Conflict of interest statement: Andrew Saykin receives support from multiple NIH \n",
      "grants (P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, U19 AG024904, \n",
      "R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01 AG072177, and U19 \n",
      "AG074879). He has also received support from Avid Radiopharmaceuticals, a \n",
      "subsidiary of Eli Lilly (in kind contribution of PET tracer precursor); Bayer \n",
      "Oncology (Scientific Advisory Board); Eisai (Scientific Advisory Board); Siemens \n",
      "Medical Solutions USA, Inc. (Dementia Advisory Board); NIH NHLBI (MESA \n",
      "Observational Study Monitoring Board); Springer-Nature Publishing (Editorial \n",
      "Office Support as Editor-in-Chief, Brain Imaging and Behavior). Li Shen has \n",
      "received additional funding paid to the University of Pennsylvania from NSF IIS \n",
      "1622526/1827472, NSF IIS 1837964, NIH RF1 AG063481, NIH R01 LM013463, NIH U01 \n",
      "AG068057, NIH R01 AG058854, NIH RF1 AG068191, NIH R01 AG071470, NIH R01 \n",
      "EB022574. Li Shen has served as consultant on NIH grant R24 EB029173 from the \n",
      "University of Massachusetts. Tatiana Foroud acts as a consultant for NIH-funded \n",
      "centers and other infrastructure grants and receives funding for travel expenses \n",
      "from the Michael J. Fox Foundation and from academic institutions on which she \n",
      "serves as advisor. Sujuan Gao has served as an unpaid board and committee member \n",
      "on the data safety monitoring board for R01 AG058586, 18G-MC-LMDC, R01 HL151951, \n",
      "and paid data safety monitoring board member for R01 AG061898. Shannon Risacher \n",
      "served as Communications Chair, unpaid, for the Alzheimer’s Association AWARE \n",
      "PIA, as well as received travel funding for the Charleston Conference on \n",
      "Alzheimer’s Disease. She also has equity interest in Eli Lilly (<$10000), a \n",
      "company that may potentially benefit in the research results of this study. Thea \n",
      "Rosewood and Kwangsik Nho have no interests to declare. The funders had no role \n",
      "in the design of this study; in the collection, analyses, or interpretation of \n",
      "data; in the writing of the manuscript; or in the decision to publish the \n",
      "results.\n",
      "\n",
      "\n",
      "6. Immunogenetics. 2023 Nov 18. doi: 10.1007/s00251-023-01325-5. Online ahead of \n",
      "print.\n",
      "\n",
      "Investigating associations between HLA DQA1 ~ DQB1 haplotypes, H. pylori \n",
      "infection, metaplasia, and anti-CagA IgA seropositivity in a Turkish gastritis \n",
      "cohort.\n",
      "\n",
      "Colakogullari M(1), Karatas L(2), Tatar Z(2).\n",
      "\n",
      "Author information:\n",
      "(1)Izmir Democracy University, Izmir, Turkey. \n",
      "mukaddes.colakogullari@yahoo.co.uk.\n",
      "(2)Izmir Democracy University, Izmir, Turkey.\n",
      "\n",
      "Helicobacter pylori was reported as an important cause of gastritis, and gastric \n",
      "ulcers and CagA oncoprotein-producing H. pylori subgroups were blamed to \n",
      "increase the severity of gastritis. Disparities were reported in that the \n",
      "presence of serum anti-CagA IgA was not parallel with CagA-positive H. pylori \n",
      "cohabitation. We hypothesized that the HLA-DQA1 ~ DQB1 haplotypes in human \n",
      "populations include protective haplotypes that more effectively present \n",
      "immunogenic CagA peptides and susceptible haplotypes with an impaired capacity \n",
      "to present CagA peptides. We recruited patients (n = 201) admitted for \n",
      "gastroendoscopy procedures and performed high-resolution HLA-DQA1 and DQB1 \n",
      "typing. Serum anti-CagA IgA levels were analyzed by ELISA (23.0% positive), and \n",
      "H. pylori was classified as positive or negative in gastric mucosal tissue \n",
      "slides (72.6% positive). The HLA DQA1*05:05 allele (29.1%) and HLA DQB1*03:01 \n",
      "allele (32.8%) were found at the highest frequency among gastritis patients of \n",
      "Turkish descent. In HLA DQA1*05:05 ~ DQB1*03:01 double homozygous (7.3%) and \n",
      "heterozygous (40.7%) haplotype carriers, the presence of anti-CagA IgA decreased \n",
      "dramatically, the presence of H. pylori increased, and the presence of \n",
      "metaplasia followed a decreasing trend. The DQ protein encoded by HLA \n",
      "DQA1*05:05-DQ*03:01 showed a low binding affinity to the CagA peptide when \n",
      "binding capacity was analyzed by the NetMHCIIPan 4.0 prediction method. In \n",
      "conclusion, HLA DQA1 ~ DQB1 polymorphisms are crucial as host defense mechanisms \n",
      "against CagA H. pylori since antigen binding capacity plays a crucial role in \n",
      "anti-CagA IgA production.\n",
      "\n",
      "© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, \n",
      "part of Springer Nature.\n",
      "\n",
      "DOI: 10.1007/s00251-023-01325-5\n",
      "PMID: 37979046\n",
      "\n",
      "\n",
      "7. Int J Mol Sci. 2023 Oct 31;24(21):15803. doi: 10.3390/ijms242115803.\n",
      "\n",
      "HLA-DQB1*06 and Select Neighboring HLA Variants Predict Chlamydia Reinfection \n",
      "Risk.\n",
      "\n",
      "Gupta K(1), Wiener HW(2), Tiwari HK(3), Geisler WM(1)(2).\n",
      "\n",
      "Author information:\n",
      "(1)Department of Medicine, Division of Infectious Diseases, University of \n",
      "Alabama at Birmingham, Birmingham, AL 35294, USA.\n",
      "(2)Department of Epidemiology, University of Alabama at Birmingham, Birmingham, \n",
      "AL 35294, USA.\n",
      "(3)Department of Biostatistics, University of Alabama at Birmingham, Birmingham, \n",
      "AL 35294, USA.\n",
      "\n",
      "Associations of HLA class II alleles with genital chlamydial infection outcomes \n",
      "have been reported, especially HLA DQB1*06. However, the potential role of \n",
      "DQB1*06 in influencing reinfection risk has still not been established. The \n",
      "purpose of this study was to determine whether the association of DQB1*06 with \n",
      "chlamydia reinfection was impacted by any other nearby HLA class II variants \n",
      "that were also associated with reinfection. We used next-generation sequencing \n",
      "to map HLA class II variants spanning the HLA-DQ and -DR loci. DQB1*06 as well \n",
      "as DQB1*04 were confirmed as significant predictors of chlamydia reinfection, \n",
      "when controlling for age and percent African ancestry. SKAT analysis revealed \n",
      "one region each in DRB1, DRB5, DQA2, and three intergenic regions that had \n",
      "variants associated with reinfection. Further analyses of these variants \n",
      "revealed that rs112651494 within DRB5 and an intergenic SNP rs617058 in \n",
      "DRB1:DQA1 were significantly associated with reinfection, but this did not \n",
      "impact the significance of the association of DQB1*06 or DQB1*04 with \n",
      "reinfection.\n",
      "\n",
      "DOI: 10.3390/ijms242115803\n",
      "PMCID: PMC10647357\n",
      "PMID: 37958786 [Indexed for MEDLINE]\n",
      "\n",
      "Conflict of interest statement: The authors declare no conflict of interest.\n",
      "\n",
      "\n",
      "8. Acta Orthop Belg. 2023 Sep;89(3):373-380. doi: 10.52628/89.2.10491.\n",
      "\n",
      "A potential prognostic prediction model for metastatic osteosarcoma based on \n",
      "bioinformatics analysis.\n",
      "\n",
      "Wang Y, Ming G, Gao B.\n",
      "\n",
      "Osteosarcoma (OS) is a malignant primary bone tumor with a high incidence. This \n",
      "study aims to construct a prognostic prediction model by screening the \n",
      "prognostic mRNA of metastatic OS. Data on four eligible expression profiles from \n",
      "the National Center for Biotechnology Information Gene Expression Omnibus \n",
      "repository were obtained based on inclusion criteria and defined as the training \n",
      "set or the validation set. The differentially expressed genres (DEGs) between \n",
      "meta- static and non-metastatic OS samples in the training set were first \n",
      "identified, and DEGs related to prognosis were screened by univariate Cox \n",
      "regression analysis. In total, 107 DEGs related to the prognosis of metastatic \n",
      "OS were identified. Then, 46 DEGs were isolated as the optimized prognostic gene \n",
      "signature, and a metastatic-OS discriminating classifier was constructed, which \n",
      "had a high accuracy in distinguishing metastatic from non-metastatic OS samples. \n",
      "Furthermore, four optimized prognostic gene signatures (ALOX5AP, COL21A1, \n",
      "HLA-DQB1, and LDHB) were further screened, and the prognostic prediction model \n",
      "for metastatic OS was constructed. This model possesses a relatively satisfying \n",
      "prediction ability both in the training set and validation set. The prognostic \n",
      "prediction model that was constructed based on the four prognostic mRNA \n",
      "signatures has a high predictive ability for the prognosis of metastatic OS.\n",
      "\n",
      "DOI: 10.52628/89.2.10491\n",
      "PMID: 37935218 [Indexed for MEDLINE]\n",
      "\n",
      "\n",
      "9. Diabetes. 2023 Nov 7:db230387. doi: 10.2337/db23-0387. Online ahead of print.\n",
      "\n",
      "Increased Frequency of the HLA-DRB1*04:04-DQA1*03-DQB1*03:02 Haplotype among \n",
      "HLA-DQB1*06:02 Positive Children with Type 1 Diabetes.\n",
      "\n",
      "Ilonen J(1), Kiviniemi M(1), El-Amir MI(1)(2), Nygård L(3), Härkönen T(4), \n",
      "Lempainen J(1)(5)(6), Knip M(4)(7); Finnish Pediatric Diabetes Register.\n",
      "\n",
      "Author information:\n",
      "(1)Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, \n",
      "Turku, Finland.\n",
      "(2)Department of Medical Microbiology and Immunology, Faculty of Medicine, South \n",
      "Valley University, Qena, Egypt.\n",
      "(3)Department of Clinical Microbiology, Institute of Clinical Medicine, \n",
      "University of Eastern Finland, Kuopio, Finland.\n",
      "(4)Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, \n",
      "University of Helsinki, Helsinki, Finland.\n",
      "(5)Departments of Pediatrics, University of Turku and Turku University Hospital, \n",
      "Turku, Finland.\n",
      "(6)Clinical Microbiology, Turku University Hospital, Turku, Finland.\n",
      "(7)Pediatric Research Center, Children's Hospital, University of Helsinki and \n",
      "Helsinki University Hospital, Helsinki, Finland.\n",
      "\n",
      "HLA DR-DQ haplotypes largely define genetic susceptibility to type 1 diabetes \n",
      "(T1D). The DQB1*06:02 positive haplotype (DR15-DQ602) common in subjects of \n",
      "European ancestry is very rare among children with T1D. Among 4490 children with \n",
      "T1D in the Finnish Pediatric Diabetes Register 57 (1.3%) cases with DQB1*06:02 \n",
      "were identified in comparison to 26.1% of affected family-based association \n",
      "controls. There was no difference between DQB1*06:02 positive and negative \n",
      "children with T1D regarding sex, age, islet autoantibody distribution or \n",
      "autoantibody levels, but significant differences were seen in the frequency of \n",
      "the second class II HLA haplotypes. The most prevalent haplotype present with \n",
      "DQB1*06:02 was DRB1*04:04-DQA1*03-DQB1*03:02 which was found in 27 of 57 (47.4%) \n",
      "children compared to only 797/4433 (18.0%) among DQB1*06:02 negative cases \n",
      "(P<0.001, Chi-square test). The other common risk associated haplotypes, the \n",
      "DRB1*04:01-DQA1*03-DQB1*03:02 and (DR3)-DQA1*05-DQB1*02 were less prevalent in \n",
      "DQB1*06:02 positive than DQB1*06:02 negative children (P<0.001). HLA-B allele \n",
      "frequencies did not differ between DQB1*06:02 haplotypes in children with T1D \n",
      "and controls and neither in DRB1*04:04-DQA1*03-DQB1*03:02 haplotypes of \n",
      "DQB1*06:02 positive and negative T1D children. The increased frequency of \n",
      "DRB1*04:04 allele among DQB1*06:02 positive cases may indicate preferential \n",
      "ability of the DR404 molecule to present islet antigen epitopes despite of the \n",
      "competition by DQ602.\n",
      "\n",
      "© 2023 by the American Diabetes Association.\n",
      "\n",
      "DOI: 10.2337/db23-0387\n",
      "PMID: 37934957\n",
      "\n",
      "\n",
      "10. Sleep Med. 2023 Dec;112:234-238. doi: 10.1016/j.sleep.2023.10.028. Epub 2023\n",
      "Oct  30.\n",
      "\n",
      "Narcolepsy type 1 and Sydenham chorea - Report of 3 cases and review of the \n",
      "literature.\n",
      "\n",
      "Wenz ES(1), Schinkelshoek MS(2), Kallweit U(3), Fronczek R(4), Rezaei R(3), \n",
      "Khatami R(5), Lammers GJ(4), Bassetti CLA(6).\n",
      "\n",
      "Author information:\n",
      "(1)Department of Neurology, Inselspital, Bern University Hospital, University of \n",
      "Bern, Bern, Switzerland; Graduate School of Health Sciences, University of Bern, \n",
      "Switzerland. Electronic address: elena.wenz@insel.ch.\n",
      "(2)Neurology Department, Leiden University Medical Center, Heemstede, the \n",
      "Netherlands.\n",
      "(3)Center for Narcolepsy and Hypersomnias, Clinical Sleep and Neuroimmunology, \n",
      "Institute of Immunology, University Witten/Herdecke, Germany.\n",
      "(4)Neurology Department, Leiden University Medical Center, Heemstede, the \n",
      "Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN), \n",
      "Sleep-Wakecenter, Heemstede, the Netherlands.\n",
      "(5)Center for Sleep Medicine and Epileptology, Klinik Barmelweid AG, \n",
      "Switzerland.\n",
      "(6)Department of Neurology, Inselspital, Bern University Hospital, University of \n",
      "Bern, Bern, Switzerland.\n",
      "\n",
      "OBJECTIVES/BACKGROUND: Narcolepsy type 1 (NT1) is an immune-mediated disorder \n",
      "characterized by excessive daytime sleepiness, cataplexy, low levels of \n",
      "hypocretin-1 in the cerebrospinal fluid, and a strong association with the HLA \n",
      "DQB1*06:02 allele. There is evidence for streptococcal infections as one \n",
      "pathogenic factor that may lead to NT1 as part of a multifactorial pathogenesis. \n",
      "Elevated titers of Antistreptolysin-O antibodies and increased inflammatory \n",
      "activity in response to streptococci antigens have been described in patients \n",
      "with NT1. Sydenham chorea (SC) results from a post-streptococcal autoimmune \n",
      "process targeting basal ganglia neurons. Despite this common trigger, SC has \n",
      "been interpreted as a misdiagnosis in a few described cases of patients who were \n",
      "first diagnosed with SC and later with NT1. Our goal was to analyze the \n",
      "association between SC and NT1.\n",
      "PATIENTS/METHODS: We reviewed the literature and report three patients from \n",
      "three European sleep centers who were diagnosed with both SC and NT1 within a \n",
      "few months.\n",
      "RESULTS: We describe the cases of one male (age 10) and two female (age 22 and \n",
      "10) patients.\n",
      "CONCLUSIONS: We argue that in those cases both diagnoses are justified, unlike \n",
      "reports of previous cases in which SC was considered a misdiagnosis in patients \n",
      "with NT1. It remains, however, unclear if the conditions occur independently or \n",
      "if there is an overlap disorder- an SC-like subtype of narcolepsy with a \n",
      "particular sequence of symptoms. Further studies need to clarify the causality \n",
      "of the relationship and the pathophysiology of the reported rare association.\n",
      "\n",
      "Copyright © 2023. Published by Elsevier B.V.\n",
      "\n",
      "DOI: 10.1016/j.sleep.2023.10.028\n",
      "PMID: 37925849 [Indexed for MEDLINE]\n",
      "\n",
      "Conflict of interest statement: Declaration of competing interest The authors \n",
      "declare the following financial interests/personal relationships which may be \n",
      "considered as potential competing interests: Elena S. Wenz reports a \n",
      "relationship with University of Bern that includes: funding grants. Ulf Kallweit \n",
      "reports a relationship with Bioprojet, Jazz Pharmaceuticals, Takeda \n",
      "Pharmaceuticals that includes: consulting or advisory and speaking and lecture \n",
      "fees. Rolf Fronczek reports a relationship with Takeda Pharmaceuticals, \n",
      "Bioprojet that includes: consulting or advisory. Rolf Fronczek reports a \n",
      "relationship with Jazz Pharmaceuticals that includes: funding grants. Gert Jan \n",
      "Lammers reports a relationship with Bioprojet, Jazz Pharmaceuticals, Takeda \n",
      "Pharmaceuticals, NLS Pharmaceutics that includes: consulting or advisory and \n",
      "speaking and lecture fees.\n"
     ]
    }
   ],
   "source": [
    "print(teste)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
